Genesco (NYSE:GCO) Upgraded at Zacks Research

Zacks Research upgraded shares of Genesco (NYSE:GCO) from a strong sell rating to a hold rating in a research note released on Wednesday,Zacks.com reports.

Several other equities analysts have also weighed in on the stock. Wall Street Zen lowered shares of Genesco from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Weiss Ratings restated a “sell (d+)” rating on shares of Genesco in a research report on Wednesday, December 24th. Truist Financial set a $38.00 price objective on shares of Genesco in a report on Wednesday. Williams Trading upgraded shares of Genesco to a “strong-buy” rating in a research report on Monday, January 12th. Finally, UBS Group set a $38.00 target price on Genesco in a research report on Friday, December 5th. Two research analysts have rated the stock with a Strong Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $36.00.

Genesco Stock Performance

NYSE GCO opened at $37.74 on Wednesday. The firm has a market capitalization of $407.34 million, a P/E ratio of -209.67 and a beta of 1.81. The stock has a 50-day simple moving average of $28.75 and a two-hundred day simple moving average of $28.30. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.30 and a current ratio of 1.58. Genesco has a fifty-two week low of $16.19 and a fifty-two week high of $43.81.

Genesco (NYSE:GCO) last posted its earnings results on Thursday, December 4th. The company reported $0.79 EPS for the quarter, missing the consensus estimate of $0.87 by ($0.08). The company had revenue of $616.22 million during the quarter, compared to analysts’ expectations of $618.62 million. During the same quarter last year, the business posted $0.61 earnings per share. Genesco has set its FY 2026 guidance at 0.950-0.95 EPS. On average, equities analysts forecast that Genesco will post 0.94 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in GCO. SG Americas Securities LLC boosted its stake in Genesco by 1.2% during the 4th quarter. SG Americas Securities LLC now owns 40,198 shares of the company’s stock worth $996,000 after purchasing an additional 458 shares during the last quarter. CWM LLC raised its position in shares of Genesco by 61.5% in the second quarter. CWM LLC now owns 1,365 shares of the company’s stock valued at $27,000 after buying an additional 520 shares during the last quarter. SummerHaven Investment Management LLC lifted its stake in shares of Genesco by 2.4% in the second quarter. SummerHaven Investment Management LLC now owns 31,295 shares of the company’s stock worth $616,000 after buying an additional 721 shares in the last quarter. BNP Paribas Financial Markets boosted its position in Genesco by 92.3% during the third quarter. BNP Paribas Financial Markets now owns 1,960 shares of the company’s stock worth $57,000 after acquiring an additional 941 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in Genesco by 6.3% during the third quarter. Russell Investments Group Ltd. now owns 18,966 shares of the company’s stock worth $550,000 after acquiring an additional 1,121 shares during the last quarter. 94.51% of the stock is owned by institutional investors and hedge funds.

Genesco Company Profile

Genesco Inc is a Nashville, Tennessee-based retailer, wholesaler and licensee specializing in branded footwear, headwear, apparel and accessories. Through its portfolio of retail chains, wholesale distribution channels and licensing agreements, Genesco brings a range of product offerings to consumers in North America and Europe.

The company’s retail segment includes specialty chains such as Journeys, which targets fashion-focused teens and young adults in the United States and Canada, and Schuh, a footwear retailer with locations in the United Kingdom and Ireland.